venBio Select Advisor »

Vera Therapeutics shares owned by venBio Select Advisor

Quarter-by-quarter ownership of Vera Therapeutics (VERA) shares owned by venBio Select Advisor from 13F filings

Historical chart of venBio Select Advisor investment in Vera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vera Therapeutics held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vera Therapeutics by venBio Select Advisor

Quarter filed Position value Share count Share price at filing
2024-03-31 $227M 5.3M 43.12

More positions owned by venBio Select Advisor

United Therapeutics Corp Common (UTHR)
Apellis Pharmaceuticals Common (APLS)
Ascendis Pharma Sponsored ADR (ASND)
Sarepta Therapeutics Common (SRPT)
Madrigal Pharmaceuticals Common (MDGL)
Argenx Se Sponsored ADR (ARGX)
Krystal Biotech Common (KRYS)
Spdr Series Trust - S&p Biotech Etf (XBI)
Biomarin Pharmaceutical Common (BMRN)
Amicus Therapeutics Common (FOLD)
Cerevel Therapeutics Hldng Common (CERE)
Viking Therapeutics Common (VKTX)
Arrowhead Pharmaceuticals Common (ARWR)
Xenon Pharmaceuticals Common (XENE)
Alpine Immune Sciences Common

View all positions for venBio Select Advisor

Top funds holding Vera Therapeutics

T. Rowe Price Associates
BlackRock
BlackRock
Sofinnova Ventures
Vanguard Group
Commodore Capital
State Street Corporation
Holocene Advisors
Kynam Capital Management
Samlyn Capital
Paradigm Biocapital Advisors
Geode Capital Management
Woodline Partners
T. Rowe Price Investment Management
Logos Global Management

View all funds holding Vera Therapeutics